EUSA Pharma discusses its innovative approach to sourcing multi-use oncology therapeutics, enabling patients to embrace life and proving a clear competitor in the therapeutics...
BioMarker Strategies introduces SnapPath®: a fluidics-based diagnostic system that enables automated and standardised ex vivo interrogation of live solid tumour cancers.
The pharmaceutical industry is...